As on 23 Oct 2026
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
EquityNAV
₹ 37.28
CAGR (3 Years)
19.06%
AUM (Cr)
₹ 1,077.52
Risk
Very High Risk
About Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be ach
Breakdown of this Fund
Chemicals
1.47%
Debt Others
5.66%
Healthcare
41.94%
Miscellaneous
1.51%
Pharmaceuticals
100.06%
Market Capitalization
Expense Ratio, Exit Load and Tax
Expense Ratio
1.4
Exit Load
Nil
Stamp Duty
0.005% (from July 1st, 2020)
Tax Implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.